美容服务
Search documents
瑞丽医美(02135)附属拟255万港元认购莱丽医美51.0%股权
Zhi Tong Cai Jing· 2026-01-06 14:48
董事会认为,认购事项符合集团的业务拓展策略。集团视认购事项为拓展香港业务范围,同时透过于香 港推广品牌及为潜在客户提供美容服务而与其现有业务实现协同效应的独特机遇。董事认为,目标公司 的营运及财务表现预期将于香港开展美容业务后有所改善,从而可为集团带来潜在投资回报。 智通财经APP讯,瑞丽医美(02135)发布公告,于2026年1月6日,缪诗美学、投资者(公司间接非全资附 属公司瑞丽美学有限公司、比夫有限公司)、股东(公司间接全资附属公司瑞丽医疗有限公司、香港翻喜 信息服务有限公司)及目标公司莱丽医美有限公司订立认购协议,缪诗美学及目标公司同意向第一投资 者瑞丽美学有限公司发行合共17万股股份,认购价为255万港元;及缪诗美学及目标公司同意向第二投资 者比夫有限公司发行合共6.33万股股份,认购价为95万港元,惟须受认购协议所载条款及条件规限。完 成后,缪诗美学、第一投资者及第二投资者将分别持有目标公司30.0%、51.0%及19.0%的股份。目标公 司将成为公司的间接非全资附属公司;且目标公司的财务业绩将于完成后并入集团账目。 目标公司(莱丽医美有限公司(前称"缪诗医学美容有限公司"))为一间于香港成立的有 ...
瑞丽医美附属拟255万港元认购莱丽医美51.0%股权
Zhi Tong Cai Jing· 2026-01-06 14:46
瑞丽医美(02135)发布公告,于2026年1月6日,缪诗美学、投资者(公司间接非全资附属公司瑞丽美学有 限公司、比夫有限公司)、股东(公司间接全资附属公司瑞丽医疗有限公司、香港翻喜信息服务有限公司) 及目标公司莱丽医美有限公司订立认购协议,缪诗美学及目标公司同意向第一投资者瑞丽美学有限公司 发行合共17万股股份,认购价为255万港元;及缪诗美学及目标公司同意向第二投资者比夫有限公司发行 合共6.33万股股份,认购价为95万港元,惟须受认购协议所载条款及条件规限。完成后,缪诗美学、第 一投资者及第二投资者将分别持有目标公司30.0%、51.0%及19.0%的股份。目标公司将成为公司的间接 非全资附属公司;且目标公司的财务业绩将于完成后并入集团账目。 目标公司(莱丽医美有限公司(前称"缪诗医学美容有限公司"))为一间于香港成立的有限公司。目标公司 尚未开展业务营运,并计划于完成后主要从事提供美容服务及其他相关服务。 董事会认为,认购事项符合集团的业务拓展策略。集团视认购事项为拓展香港业务范围,同时透过于香 港推广品牌及为潜在客户提供美容服务而与其现有业务实现协同效应的独特机遇。董事认为,目标公司 的营运及财务表 ...
品质为大·诚信为友
Xin Lang Cai Jing· 2025-12-25 17:24
作为山东省大型综合商业集团,大友立足济南,辐射山东。一直秉持"以人为本·顾客第一"的儒商经营哲学, 坚守"品质为大·诚信为友"的客户服务理念,发扬"诚信、专业、创新、超越客户期待"的企业精神,矢志成 为"最值得信赖的综合类商业集团"。 大友汽车 大友集团自2000年成立以来,成就斐然。连续多年斩获"中国汽车经销商百强集团"、济南市总部企业、 济南民营企业100强、山东省诚信企业等诸多荣誉。集团经营范围广泛,覆盖汽车、金融、航空、房地产 四大产业,手握AITO问界、鸿蒙智行尚界、纵横、宝马、宝马摩托车、广汽丰田、东风本田7大品牌。 在山东省内,大友集团构建起广泛的授权4S店经销商网络,覆盖济南、青岛、泰安、淄博、济宁等经济高 速发展的地区与城市。大友汽车专注经营豪华和中高档品牌,旗下拥有13家授权标准4S店,其中东风本田 市占率居全省第一,广汽丰田品牌单店销量稳居全省第一,以硬核的销售实力和品牌运营能力,成为山东汽 车经销领域的标杆力量。 2024年成立的集团首家新能源用户中心-问界AITO授权用户中心·济南经十东路店,经过一年多的稳健运 营,已成为山东区域智慧出行服务的重要节点。该中心由集团副董事长牟延存亲自 ...
美丽田园医疗健康(02373.HK)点评:内生+外延双轮驱动 聚焦三大超级战略
Ge Long Hui· 2025-12-19 21:48
增持奈瑞儿股权至90%,收购后整合提效明显。2024 年3 月,公司宣布收购奈瑞儿70%股权,总对价为 3.50 亿元。按收入计算,奈瑞儿为中国传统美容服务第二大品牌,主要业务网络分布广州和深圳。此 外,2024 年7 月,公司宣布通过特许经营的方式将奈瑞儿剩余的75 家门店纳入其业务网络,合计将新 增150 家门店。2025 年5 月,公司宣布以1.0 亿人民币收购广州奈瑞儿20%股权,持股比例提升至90%。 此外,今年11 月,公司宣布以4,000 万元收购珠海和东莞19 家奈瑞儿加盟门店,进一步强化大湾区布 局。2025 年上半年,奈瑞儿收入达到2.77 亿元,收购后整合提效明显,经调整净利率从收购前的6.5% 提升至10.4%。 聚焦三大超级战略,助力长期发展。11 月19 日,公司举行战略升级发布会,宣布未来三大超级战略: 超级品牌、超级连锁、超级数字化。超级品牌方面,目前公司已整合行业前三品牌,包括美丽田园、奈 瑞儿、思妍丽,持续强化品牌优势。超级连锁方面,以"双美 + 双保健"为核心模式,通过内生+外延双 轮驱动,计划国内过亿元收入城市数量达到20 个,实现北京、上海单城收入超10 亿。超级数字 ...
奥思集团公布年度业绩 公司拥有人应占溢利8125.8万港元 同比增长19%
Zhi Tong Cai Jing· 2025-12-15 11:25
Core Viewpoint - Aosi Group (01161) reported its annual results for the year ending September 30, 2025, showing a slight decrease in revenue but a significant increase in profit attributable to shareholders [1] Financial Performance - Revenue for the year was approximately HKD 981 million, representing a year-on-year decrease of 0.19% [1] - Profit attributable to shareholders was HKD 80.887 million, reflecting a year-on-year increase of 19% [1] - Earnings per share were HKD 0.119, with a proposed final dividend of HKD 0.025 per share [1] Operational Highlights - The growth in profit was attributed to the company's prudent financial management and cost optimization measures [1] - The company successfully leveraged economies of scale and maintained a strong commitment to service quality and providing an exceptional beauty experience for customers [1]
美丽田园医疗健康(02373):战略升级:锚定“20城超1亿”,全面贯彻“三大超级”战略
Haitong Securities International· 2025-11-21 05:49
Investment Rating - The report assigns an "Outperform" rating to Beauty Farm Medical and Health Industry, expecting a relative return exceeding 10% over the next 12-18 months [24]. Core Insights - Beauty Farm has articulated a clear strategy centered around the "Three Super" initiatives: Super Brand, Super Chain, and Super Digitalization, aiming to build core competitive advantages in the beauty services industry [2][9]. - The company targets to establish operational entities with revenues exceeding RMB 100 million in 20 core cities, which contribute approximately 40% of the industry revenue, with a solid foundation already in place as 8 cities have achieved this target [3][10]. - Recent operational performance shows strong momentum, with same-store sales growth of 6-8% and collection growth accelerating to low double digits, indicating robust endogenous growth [4][11]. Summary by Sections Strategic Overview - The "Three Super" strategy focuses on enhancing brand value, expanding chain operations, and leveraging digitalization to deepen customer relationships and operational efficiency [2][9]. - The company has integrated three premium brands to secure a strong position in the high-end market and aims to enhance customer experience through personalized services [2][9]. Growth Strategy - The goal is to increase the number of cities generating over RMB 100 million in revenue from 8 to 20 in the near term, with a focus on developing Shanghai and Beijing into "super cities" with revenues exceeding RMB 1 billion each [3][10]. - The growth will be driven by both organic growth and strategic acquisitions, leveraging successful past experiences in markets like Chongqing and Xi'an [3][10]. Financial Performance - The company has demonstrated exceptional profit enhancement capabilities, with significant improvements in revenue per store and profit margins post-acquisition [4][11]. - Strong cash flow generation is projected, with estimated operating cash flow of approximately RMB 1 billion for FY25, supporting future shareholder returns and strategic acquisitions [4][11]. Industry Context - The beauty services industry in China is highly fragmented, with nearly 90% of operations being single-store, presenting significant opportunities for consolidation driven by branding, chainification, and digitalization [5][12]. - The company anticipates a decrease in the total number of industry stores, while the market share and profitability of leading players with strong branding and digital capabilities will increase significantly [5][12]. M&A Strategy - Proven M&A integration capabilities are a key engine for executing the Super Chain strategy, with over 30 successful transactions completed historically [6][13]. - The recent integration of Naturade has validated the effectiveness of the company's platform-based empowerment model, with expectations of similar success from the newly acquired DECLÉOR [6][13].
消费前如何有效避坑?这几个方法一定要掌握
Xin Lang Cai Jing· 2025-11-17 07:52
Core Viewpoint - The article emphasizes the importance of consumer awareness and proactive measures to avoid pitfalls in various industries, highlighting practical methods for risk identification and complaint channels to enhance consumer protection. Group 1: Identifying Industry Risks - Different industries have unique risk points due to variations in service models, regulatory intensity, and market maturity, with online education being a notable example where course quality and refund mechanisms are often problematic [2][3] - Other sectors like tourism, beauty, and home renovation also face issues such as "bait pricing," hidden fees, and substandard service quality, making it essential for consumers to understand industry characteristics to mitigate risks [3] Group 2: Utilizing Third-Party Platforms - Third-party platforms are becoming crucial for consumers to obtain authentic feedback, with platforms like Black Cat Complaints providing a space for real user complaints that reflect a company's service and product quality [4] - Black Cat Complaints allows easy access through multiple channels, enabling consumers to quickly submit complaints and participate in consumer rights protection [4] Group 3: Industry-Specific Complaint Channels - Different industries require specialized complaint channels for effective resolution, with Black Cat Complaints contributing to regulatory oversight by reporting product quality issues to authorities [5] Group 4: Preventive and Rights Protection Strategies - Consumers should maintain a dual approach of prevention and rights protection, which includes keeping receipts, verifying company qualifications, and scrutinizing contract terms [6][7] - Specific complaint channels are available for various sectors, such as transportation, telecommunications, e-commerce, financial services, and automotive, ensuring consumers have access to appropriate resources for addressing issues [8] Group 5: Conclusion - Developing an awareness of potential pitfalls before consumption is a fundamental skill for modern consumers, and utilizing available resources can significantly reduce the likelihood of negative experiences [9]
中信建投:维持美丽田园医疗健康“增持”评级 收购思妍丽完善布局
Zhi Tong Cai Jing· 2025-11-10 08:26
Core Viewpoint - The acquisition of Siyuanli by Meili Tianyuan Medical Health is expected to strengthen its position in the mid-to-high-end beauty care service market, with potential for further optimization in its business model through both organic and external growth strategies [1][2]. Group 1: Acquisition Details - The company announced the acquisition of 100% equity of Siyuanli for a consideration of 1.25 billion RMB [1]. - Siyuanli is the third-largest beauty service brand in China, with projected revenue of 849 million RMB in 2024 and operations in 48 cities with 163 beauty stores and 19 medical beauty clinics [2]. - The acquisition will consolidate the company’s competitive position by bringing together the top three beauty service brands and capturing 42% of high-end commercial properties in first- and second-tier cities [2]. Group 2: Financial Projections - The company updated its net profit forecasts for 2025-2027 to 372 million, 409 million, and 486 million RMB, respectively, with corresponding PE ratios of 18X, 17X, and 14X [1]. - Siyuanli is expected to achieve a net profit of 81 million RMB in 2024, with potential for profit margin improvement similar to the company’s previous acquisition of Nairui, which saw an increase from 6.5% in 2023 to 10.4% in the first half of 2025 [2]. Group 3: Shareholder Returns - The company plans to maintain a dividend payout of no less than 50% of the net profit attributable to shareholders for the next three complete financial years [1][2]. - The company has been actively repurchasing shares, having bought back 605,500 shares out of an authorized 23.58 million shares, to support its market price [2].
光大证券:维持美丽田园医疗健康“买入”评级 12亿港元大额股东回报计划夯实信心
Zhi Tong Cai Jing· 2025-11-10 02:12
Group 1 - The core viewpoint of the report is that the acquisition of Siyuanli will directly enhance the company's performance, leading to an upward revision of the net profit forecasts for 2025-2027 to 320 million, 440 million, and 490 million RMB, representing increases of 5%, 26%, and 21% respectively, with corresponding EPS of 1.36, 1.86, and 2.09 RMB, and current PE ratios of 20, 14, and 13 times [1] - The company announced a long-term shareholder return plan, expecting to utilize up to 1.2 billion HKD over the next three years to provide returns to shareholders [1] Group 2 - The shareholder return plan will be implemented through two main methods: first, an annual dividend of no less than 50% of the company's net profit attributable to shareholders; second, a continuous share buyback program [2] - This substantial shareholder return plan reflects the company's strong confidence in future development and highlights its solid cash flow foundation and overall strength [2] Group 3 - The company announced a strategic acquisition of 100% equity in Siyuanli for 1.25 billion RMB, which is the third-largest beauty service brand in China, with a significant presence in major cities [3] - Following the acquisition, approximately 60,000 active members from Siyuanli will be integrated into the company's membership system, leading to a more than 44% increase in active membership [3] - The company's market share in high-tier cities will significantly increase, further solidifying its position as an industry leader [3] Group 4 - The company's growth is driven by both internal and external factors, with a dual business model of "dual beauty + dual healthcare" effectively building a high-quality membership system [4] - The successful acquisition of the second-largest brand, Nairui, has demonstrated the company's integration and synergy capabilities, with Nairui's adjusted net profit margin increasing from 6.5% to 10.4% in the first half of 2025 [4] - The company is expected to leverage its extensive acquisition experience to enhance Siyuanli's operational efficiency and achieve mutual empowerment between the Siyuanli and Meili Tianyuan brands, thereby continuously improving its industry influence and competitiveness [4]
拟12亿港元回馈股东!美丽田园股价涨逾3%
Sou Hu Cai Jing· 2025-11-05 07:21
Core Viewpoint - Meili Tianyuan Medical Health (02373.HK) announced a significant shareholder return plan, intending to utilize up to HKD 1.2 billion over the next three years through dividends and share buybacks [2][3]. Group 1: Shareholder Return Plan - The company plans to distribute annual dividends amounting to no less than 50% of the net profit attributable to shareholders for the next three complete financial years [3]. - The company has received authorization to repurchase up to 23.5796 million shares under the existing buyback authorization, with 605,500 shares already repurchased as of November 4 [3][5]. Group 2: Market Reaction and Analysis - Following the announcement, the stock price of Meili Tianyuan rose by 3.13%, reaching HKD 30.34 per share [2]. - Analysts believe the feasibility of the shareholder return plan hinges on the company's ability to deliver stable performance, which is essential for sustaining shareholder returns [2][5]. - The management's decision to implement this plan is seen as a confidence signal in the company's long-term value, especially amid recent stock price declines [5]. Group 3: Future Considerations - The success of the shareholder return plan will ultimately depend on the company's ability to fulfill its commitments and demonstrate performance through quarterly results [5]. - Meili Tianyuan is also anticipated to be a contender for the "Top 100 Hong Kong Stocks" list, which could further enhance its market position [5].